AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury
J. Clin. Invest. Raymond R. Russell, et al. 114:495
doi:10.1172/JCI19297 [Go to this article.]

Figure 7
Myocardial injury and apoptotic activity following low-flow ischemia. Release of myocardial creatine kinase (CK) and lactate dehydrogenase (LDH) from WT (n = 7) and KD (n = 6) transgenic hearts during ischemia and reperfusion (A and B). Caspase-3 activity following baseline perfusion (n = 3 for both groups) and following ischemia/reperfusion (n = 7 for WT and n = 6 for KD) (C). Quantification of apoptotic nuclei from WT and KD hearts (n = 3 for both) following ischemia/reperfusion (D). Representative composite confocal photomicrographs of sections from WT and KD hearts following reperfusion (E and F). Hearts underwent TUNEL staining with fluorescein-labeled dUTP and counterstaining with propidium iodide. TUNEL-positive nuclei are stained yellow (arrows). *P < 0.05 versus WT; P < 0.05 versus ischemia; P < 0.05 versus baseline.